E Fund Management Co., Ltd. Vbi Vaccines Inc Transaction History

E Fund Management Co., Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.66 - $1.81 $35,077 - $96,197	-53,148 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$1.27 - $2.47 $33,426 - $65,010	26,320 Added 98.11%	53,148 $88,000
Q4 2021 Feb 11, 2022	BUY	$2.21 - $3.22 $2,110 - $3,075	955 Added 3.69%	26,828 $63,000
Q3 2021 Nov 12, 2021	SELL	$2.8 - $3.72 $47,756 - $63,448	-17,056 Reduced 39.73%	25,873 $80,000
Q1 2021 May 12, 2021	BUY	$2.91 - $4.32 $124,923 - $185,453	42,929 New	42,929 $133,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of E Fund Management Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on E Fund Management Co., Ltd. with notifications on news.